Preclinical CRO Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Preclinical CRO Market size is expected to grow at an annual average of 7% during 2021-2027. Conducting preclinical trials, proof-of-concept (POC), and first-in-human (FIH) as multicenter studies can provide significant advantages in finding the correct target population and improving recruitment. Therefore, preclinical CRO services are an important part of effective drug development that will accelerate market demand. In addition, technological innovations that provide efficacy and safety during product development will drive the expansion of the preclinical CRO industry.

The following segmentation are covered in this report:

By Service

• Bioanalysis & DMPK studies
• Toxicology testing
• Others

By End-use

• Biopharmaceutical companies
• Government & academic institute
• Medical device companies
• Others

Company Profile

• Envigo Corp.
• MPI Research
• Eurofins Scientific
• PRA Health Sciences, Inc.
• Wuxi AppTec
• Medpace, Inc.
• Pharmaceutical Product Development (PPD), LLC
• PARAXEL International Corp.
• ICON Plc
• Laboratory Corporation of America, Inc.

Scope of the report

The research study analyses the Preclinical CRO Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Preclinical CRO Market Report

• What was the Preclinical CRO Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Preclinical CRO Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.